Stockscreener 앱 받기
12.13
3.72%
0.435
전일 마감가:
$11.70
열려 있는:
$12.27
하루 거래량:
37,560
Relative Volume:
0.32
시가총액:
$144.19M
수익:
$3.25M
순이익/손실:
$-116.80M
주가수익비율:
-3.9787
EPS:
-3.05
순현금흐름:
$-98.17M
1주 성능:
+14.37%
1개월 성능:
+63.32%
6개월 성능:
+24.33%
1년 성능:
-51.54%
1일 변동 폭
$11.62
$12.27
1주일 범위
$10.00
$12.40
52주 변동 폭
$5.6652
$27.84
Rapt Therapeutics Inc Stock (RAPT) Company Profile
명칭
Rapt Therapeutics Inc
전화
(650) 489-9000
주소
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
RAPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
12.07 | 144.19M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.80 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.83 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.11 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
573.86 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.64 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-22 | 재개 | H.C. Wainwright | Buy |
| 2024-12-26 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-11-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-11-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-11-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-14 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-05-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-02-21 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-02-21 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | 개시 | Evercore ISI | Outperform |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-09-14 | 개시 | Berenberg | Buy |
| 2023-08-09 | 개시 | Stifel | Buy |
| 2023-06-15 | 개시 | Barclays | Overweight |
| 2023-01-04 | 개시 | Guggenheim | Buy |
| 2022-12-01 | 개시 | Goldman | Buy |
| 2022-09-21 | 개시 | CapitalOne | Overweight |
| 2022-05-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-09 | 개시 | JP Morgan | Overweight |
| 2021-08-12 | 개시 | SVB Leerink | Outperform |
| 2021-06-21 | 개시 | Piper Sandler | Overweight |
| 2020-06-01 | 개시 | H.C. Wainwright | Buy |
| 2020-05-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-04-13 | 개시 | ROTH Capital | Buy |
| 2019-11-25 | 개시 | BMO Capital Markets | Outperform |
| 2019-11-25 | 개시 | UBS | Buy |
| 2019-11-25 | 개시 | Wells Fargo | Outperform |
모두보기
Rapt Therapeutics Inc 주식(RAPT)의 최신 뉴스
What drives RAPT Therapeutics Inc. stock priceTriple-digit wealth increases - jammulinksnews.com
RAPT Therapeutics Inc. Stock Analysis and ForecastExplosive capital gains - jammulinksnews.com
What makes RAPT Therapeutics Inc. stock price move sharplyFree Access to Investment Community - Newser
What analysts say about RAPT Therapeutics Inc. stockRapid growth trajectories - Autocar Professional
Is RAPT Therapeutics Inc. a good long term investmentHigh-performance investment picks - jammulinksnews.com
How RAPT Therapeutics Inc. stock performs during market volatilityTop Performer Shortlist - Newser
Why RAPT Therapeutics Inc. stock attracts strong analyst attentionSafe Entry High Exit Alerts - Newser
Rapt Therapeutics (RAPT) Upgraded to Strong Buy: Here's Why - Yahoo Finance
RAPT Therapeutics Explodes 20%—What's Fueling the Surge? - AInvest
RAPT Therapeutics Soars 24%—What’s Fueling the Breakout? - AInvest
Best Momentum Stocks to Buy for July 15th - TradingView
Does Rapt Therapeutics (RAPT) Have the Potential to Rally 183.83% as Wall Street Analysts Expect? - Yahoo Finance
HC Wainwright Analysts Decrease Earnings Estimates for RAPT - Defense World
HC Wainwright Forecasts Strong Price Appreciation for Rapt Therapeutics (NASDAQ:RAPT) Stock - Defense World
Rapt Therapeutics (NASDAQ:RAPT) Price Target Raised to $27.00 - Defense World
RAPT Therapeutics Unveils Plans for RPT904 Development - TipRanks
Rapt Therapeutics (NASDAQ:RAPT) Given Average Rating of “Hold” by Analysts - Defense World
RAPT Therapeutics Expands Board with New Appointments - TipRanks
Wall Street Analysts Predict a 282.65% Upside in Rapt Therapeutics (RAPT): Here's What You Should Know - Yahoo Finance
RAPT Therapeutics Executes 1-for-8 Reverse Stock Split - TipRanks
RAPT Therapeutics (RAPT) Trading Halted as News Awaits Release | RAPT Stock News - GuruFocus
Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace
Rapt Therapeutics announces effective date for 1-for-8 reverse stock split - Yahoo Finance
# RAPT Therapeutics to implement 1-for-8 reverse stock split By Investing.com - Investing.com South Africa
RAPT Finalizes Reverse Split Plan; 1-for-8 Ratio Effective June 16, 2025 - Nasdaq
RAPT Therapeutics Shares to Start Trading on a Split-Adjusted Basis Tuesday - marketscreener.com
RAPT Therapeutics Announces Effective Date For 1-For-8 Reverse Stock Split - MarketScreener
RAPT Therapeutics Announces Reverse Stock Split Effective June 2025 | RAPT Stock News - GuruFocus
# RAPT Therapeutics to implement 1-for-8 reverse stock split - Investing.com
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split - GlobeNewswire
RAPT Therapeutics Announces Major Share Consolidation: 132M Shares Shrinking to 16.5M in Reverse Split - Stock Titan
Two Sigma Investments LP Sells 339,957 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
Transcript : RAPT Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 09 - MarketScreener
Rapt Therapeutics Inc (RAPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.55%
자본화:
|
볼륨(24시간):